Endocrine/metabolicChia Tai Tianqing Pharmaceutical discovers new GIPR antagonistsChia Tai Tianqing Pharmaceutical Group Co. Ltd. has patented new gastric inhibitory polypeptide receptor (GIPR) antagonists potentially useful for the treatment of metabolic diseases.